ORIGINAL RESEARCH
Published on 23 Dec 2024
Eosinophil is a Predictor of Severe Immune-Related Adverse Events Induced by Ipilimumab plus Nivolumab Therapy in Patients with Renal Cell Carcinoma: A Retrospective
doi 10.3389/fimmu.2024.1483956
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Biomarkers of Immunotoxicity from Immune Checkpoint Inhibitors
Biomarkers of Immunotoxicity from Immune Checkpoint Inhibitors
7,596
Total Downloads
22k
Total Views and Downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
REVIEW
Published on 11 Dec 2024
Advances in biomarkers for immunotherapy in small-cell lung cancer
doi 10.3389/fimmu.2024.1490590
- 190 views
CASE REPORT
Published on 22 Nov 2024
Clinical characteristics and biomarkers of severe immune checkpoint inhibitor-related pneumonitis triggered by immunotherapy followed by radiation: a case report
doi 10.3389/fimmu.2024.1454114
- 331 views
ORIGINAL RESEARCH
Published on 10 Oct 2024
Biomarkers in the early stage of PD-1 inhibitor treatment have shown superior predictive capabilities for immune-related thyroid dysfunction
doi 10.3389/fimmu.2024.1458488
- 603 views
SYSTEMATIC REVIEW
Published on 23 Sep 2024
Neutrophil-to-lymphocyte ratio as a predictive biomarker for hyperprogressive disease mediated by immune checkpoint inhibitors: a systematic review and meta-analysis
doi 10.3389/fimmu.2024.1393925
- 567 views
REVIEW
Published on 23 Aug 2024
Toxicity in the era of immune checkpoint inhibitor therapy
doi 10.3389/fimmu.2024.1447021
- 2,379 views
ORIGINAL RESEARCH
Published on 25 Jun 2024
The prognostic impact of severe grade immune checkpoint inhibitor related pneumonitis in non-small cell lung cancer patients
doi 10.3389/fonc.2024.1372532
- 612 views
ORIGINAL RESEARCH
Published on 16 Apr 2024
Highly variable timing renders immunotherapy efficacy and toxicity impractical biomarkers of one another in clinical practice
doi 10.3389/fimmu.2024.1351739
- 830 views
REVIEW
Published on 15 Mar 2024
Aging-related biomarker discovery in the era of immune checkpoint inhibitors for cancer patients
doi 10.3389/fimmu.2024.1348189
- 2,160 views
- 4 citations
REVIEW
Published on 05 Feb 2024
Immune checkpoint inhibitors associated cardiovascular immune-related adverse events
doi 10.3389/fimmu.2024.1340373
- 4,532 views
- 4 citations
ORIGINAL RESEARCH
Published on 29 Jan 2024
Germline DNA damage response gene mutations as predictive biomarkers of immune checkpoint inhibitor efficacy
doi 10.3389/fimmu.2024.1322187
- 1,041 views
ORIGINAL RESEARCH
Published on 29 Jan 2024
The impact of pulmonary artery to ascending aorta diameter ratio progression on the prognosis of NSCLC patients treated with immune checkpoint inhibitors
doi 10.3389/fimmu.2024.1302233
- 893 views
Published in
Frontiers in Immunology
- Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Impact
- 22kTopic views
- 13kArticle views
- 7,596Article downloads